Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Richard Daniell on LinkedIn: Teva Reports First Quarter 2022 Financial Results
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Roberta Metsola on X: "Europe stands for jobs, innovation & investment. In Malta, I visited Teva Pharmaceuticals, one of the EU's healthcare strategic partners & global leader in generic medicine. Research &
Securing Supply in Europe – where does Teva api fit it? | Teva api
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva, Cephalon Lose Fight Over EU's Antitrust Sleep Drug Fine - Bloomberg
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva rolls along in 2nd year of 'Pivot to Growth' strategy
Teva Pharmaceuticals Europe
EX-99.1
Teva profit plummets, stock slides | Ctech
Teva, Allergan Tweak Acquisition Agreement - WSJ
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | CNN
Allergan steps away from generics with sale to Teva | Business | Chemistry World